Healthcare & Biotech

SHERIDAN, WYOMING -- June 15, 2026 -- Dentsply Sirona has appointed John Fortson as Executive Vice President and Chief Financial Officer, effective July 20, 2026. Fortson joins from Kymera International, where he served as President and CFO, and brings more than 25 years of finance, operations, and strategy experience across global manufacturing and industrial businesses. The appointment is framed by the company as a key step in advancing its Return-to-Growth Action Plan.

SHERIDAN, WYOMING -- June 15, 2026 -- VOCO has become a Gold Sponsor of the FDI World Dental Federation, with the partnership centred on the FDI's Master Continuing Education Programme in adhesive and aesthetic dentistry. The five-module programme delivers specialised clinical training to dental professionals globally, combining theoretical content with practical application under guidance from established speakers in the field. VOCO's sponsorship includes both financial support and provision of composite materials for hands-on use during seminars.

SHERIDAN, WYOMING -- June 15, 2026 -- VOCO has introduced a range of fluorescent dental materials spanning temporary luting, temporary filling, core build-up, and aligner attachment workflows. The four products — Bifix Temp fluorescent, Clip F fluorescent, Rebilda DC fluorescent, and AlignerFlow LC — each carry UV-A-activated fluorescence that makes excess material and residues visible without altering aesthetics under natural light. The approach addresses a practical clinical problem: material residues that are difficult to detect with the naked eye but consequential for the quality of subsequent restorations and treatments.

SHERIDAN, WYOMING -- June 15, 2026 -- Roche has received FDA approval for the VENTANA PTEN (SP218) RxDx Assay, the first immunohistochemistry companion diagnostic cleared to assess PTEN protein loss in patients with prostate adenocarcinoma. The assay identifies patients whose tumours exhibit PTEN deficiency, making them potentially eligible for treatment with AstraZeneca's TRUQAP in combination with abiraterone acetate. Approval is based on results from the CAPItello-281 clinical study, where the assay served as the enrollment diagnostic to identify patients with PTEN-deficient tumours.

SHERIDAN, WYOMING -- June 15, 2026 -- The U.S. Food and Drug Administration has accepted Roche's supplemental Biologics License Application for Tecentriq and Tecentriq Hybreza in combination with chemotherapy as an adjuvant treatment for stage III dMMR/MSI-H colon cancer following surgery. The FDA has granted Priority Review and is expected to issue a decision by October 9, 2026. The filing is supported by Phase III ATOMIC study data showing a 50% reduction in the risk of disease recurrence or death compared to chemotherapy alone, results published in The New England Journal of Medicine.

SHERIDAN, WYOMING -- June 15, 2026 -- Dentsply Sirona has launched the WaveOne® Gold Orifice Shaper, its first reciprocating coronal flaring instrument, now available in the United States and Canada. The file is designed to integrate directly into the existing WaveOne® Gold treatment protocol, using the same reciprocating motion and motor settings as the rest of the system. That compatibility eliminates the need to change motor configurations during root canal preparation — a practical workflow improvement that reduces procedural complexity and the risk of operator error.

SHERIDAN, WYOMING -- June 9, 2026 -- Philips has put its VeriSight Pro 3D intracardiac echocardiography (ICE) technology in front of a wider audience through a feature on the BBC's technology program Tech Now, filmed during a live structural heart procedure in Copenhagen. The technology places a miniature ultrasound probe on the tip of a catheter, threading it through a vein into the heart to deliver real-time three-dimensional images of anatomy, valves, and treatment devices. For interventional teams, it offers an alternative to passing a larger probe down the patient's esophagus under general anaesthesia. The result is a more precise and less invasive route to treating structural heart disease.

SHERIDAN, WYOMING -- June 9, 2026 -- Philips has released its Future Health Index 2026, the 11th edition of its annual global study, drawing on responses from more than 2,000 healthcare professionals and over 20,000 patients across 10 countries. The findings show that artificial intelligence already saves clinicians the equivalent of more than 16 working days each year and is helping many of them treat additional patients. At the same time, the report warns that inadequate training and fragmented IT infrastructure could leave some health systems behind. For hospital leaders and care providers, the results frame AI less as a future prospect and more as an operational tool already reshaping daily workloads.

SHERIDAN, WYOMING -- June 7, 2026 -- Ivoclar has published clinical practice guidance for dental professionals working with the Tetric plus composite system, focusing on combined workflows involving Tetric plus Flow and Tetric plus Fill in anterior restorations. The guidance positions Tetric plus Flow as a single-material replacement for both Tetric EvoFlow and Tetric PowerFlow, built around its thixotropic properties — controlled, precise application alongside strong flow when required. Three tips address contouring support, surface imperfection repair and volume or transition adjustment in Class IV, Class V and direct veneer procedures. OptraSculpt Pad and OptraGloss are recommended as supporting instruments throughout.

SHERIDAN, WYOMING -- June 6, 2026 -- Henry Schein, Inc. has elected William K. "Dan" Daniel as Independent Chairman of the Board effective May 21, 2026, as Stanley M. Bergman steps down following 44 years as a Director of the company. Daniel joined the Henry Schein board in May 2025 and brings executive leadership experience across healthcare and industrial businesses, including a 14-year tenure as Executive Vice President at Danaher Corporation. The election places a leader with direct experience in dental sector governance and operations in the chair role at the world's largest provider of healthcare solutions to office-based dental and medical practitioners. Bergman has been named Chairman Emeritus.